LeonaBio (LONA) Assets Average (2020 - 2026)

LeonaBio (LONA) has 7 years of Assets Average data on file, last reported at $81.9 million in Q1 2026.

• Assets Average for Q1 2026 came in at $81.9 million, up 60.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $81.9 million (up 60.07% YoY), and the FY2025 annual result was $75.5 million, down 31.09% from the prior year.
• Assets Average grew to $81.9 million in Q1 2026 per LONA's latest filing, from $61.1 million in the prior quarter.
• Over five years, Assets Average peaked at $322.5 million in Q1 2022 and troughed at $32.8 million in Q3 2025.
• A 5-year average of $159.8 million and a median of $146.9 million in 2024 frame the typical range for Assets Average.
• The sharpest annual moves came in 2025 and 2026: Assets Average slumped 67.69% in 2025, then jumped 60.07% in 2026.
• A 5-year view of Assets Average shows it stood at $266.2 million in 2022, then sank by 35.2% to $172.5 million in 2023, then tumbled by 57.96% to $72.5 million in 2024, then declined by 15.75% to $61.1 million in 2025, then jumped by 34.01% to $81.9 million in 2026.
• Business Quant data shows LONA's Assets Average at $81.9 million in Q1 2026, $61.1 million in Q4 2025, and $32.8 million in Q3 2025.